Wecan Medicare is developing an innovative product to support the advancement of medical technology. Listening to the voice from hospitals, we explore the potential needs, commercialize them and supply the new products to hospitals which can lead to the improvement of health care.
Pursuing the best quality is only meaningful and will generate a consistent benefit to patients, hospitals and the society. It is a corporate philosophy and principle.
S-protector was developed by James Kim, the founder of Wecan Medicare with a leading surgeon in Thyroid surgery. It improved the combined function of surgical wound protector and retractor. To make the world best product, we have prepared the PCT application, certificate of ISO 13485 and a qualified GMP system. CE approval is scheduled by late 2016 and US FDA approval is expected by late 2017.